Pheochromocytomas Active Not Recruiting Phase 2 Trials for Sunitinib (DB01268)

Also known as: Pheochromocytoma / Chromaffin cell neoplasm (morphologic abnormality) / Phaeochromocytoma / Pheochromocytoma (morphologic abnormality) / Phaeochromocytoma [Ambiguous]

IndicationStatusPhase
DBCOND0071316 (Pheochromocytomas)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00843037Study Of Sunitinib In Patients With Recurrent Paraganglioma/PheochromocytomaTreatment